Challenges surround RSV vaccine rollout in the US
chinadaily.com.cn | Updated: 2023-10-13 08:59
In preparation for RSV prevalence expected in the coming winter, the US Centers for Disease Control and Prevention and the Food and Drug Administration in July approved an RSV vaccine for infants and children under the age of 2. However, the distribution and supply of the new vaccine are facing challenges.
Editor's Pick
